STOCK TITAN

[SCHEDULE 13G] Caris Life Sciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

On 28 Jul 2025, TSSP Sub-Fund HoldCo, LLC and its managing member Alan Waxman jointly filed a Schedule 13G disclosing passive ownership in Caris Life Sciences, Inc. ("CAI") as of 30 Jun 2025.

  • TSSP Sub-Fund HoldCo: 23,166,128 shares (8.3 % of the 277,932,779 outstanding).
  • Alan Waxman: deemed beneficial owner of 24,385,399 shares (8.8 %) through control of HoldCo and related Sixth Street vehicles.
  • Shares are distributed across five entities including Barnett Equity Holdings, Sixth Street Specialty Lending Inc. and related investment LLCs.

Both filers report zero sole and shared voting/dispositive power over the respective share counts; ownership is reported under Rule 13d-1(c) as a passive investment. No additional transactions, changes in control, or certifications were disclosed.

Il 28 luglio 2025, TSSP Sub-Fund HoldCo, LLC e il suo membro gestore Alan Waxman hanno presentato congiuntamente un Schedule 13G, dichiarando una partecipazione passiva in Caris Life Sciences, Inc. ("CAI") al 30 giugno 2025.

  • TSSP Sub-Fund HoldCo: 23.166.128 azioni (8,3% delle 277.932.779 azioni in circolazione).
  • Alan Waxman: considerato beneficiario effettivo di 24.385.399 azioni (8,8%) tramite il controllo di HoldCo e dei veicoli correlati di Sixth Street.
  • Le azioni sono distribuite tra cinque entità, tra cui Barnett Equity Holdings, Sixth Street Specialty Lending Inc. e LLC di investimento correlate.

Entrambi i presentatori dichiarano zero poteri di voto o dispositivi individuali e condivisi sulle rispettive azioni; la proprietà è segnalata ai sensi della Regola 13d-1(c) come investimento passivo. Non sono state divulgate ulteriori transazioni, cambiamenti di controllo o certificazioni.

El 28 de julio de 2025, TSSP Sub-Fund HoldCo, LLC y su miembro administrador Alan Waxman presentaron conjuntamente un Schedule 13G, revelando una propiedad pasiva en Caris Life Sciences, Inc. ("CAI") al 30 de junio de 2025.

  • TSSP Sub-Fund HoldCo: 23,166,128 acciones (8.3% de las 277,932,779 en circulación).
  • Alan Waxman: considerado beneficiario efectivo de 24,385,399 acciones (8.8%) a través del control de HoldCo y los vehículos relacionados de Sixth Street.
  • Las acciones están distribuidas entre cinco entidades, incluyendo Barnett Equity Holdings, Sixth Street Specialty Lending Inc. y LLCs de inversión relacionadas.

Ambos declarantes reportan cero poder individual y compartido de voto/disposición sobre las acciones respectivas; la propiedad se informa bajo la Regla 13d-1(c) como una inversión pasiva. No se divulgaron transacciones adicionales, cambios de control ni certificaciones.

2025년 7월 28일, TSSP Sub-Fund HoldCo, LLC와 그 관리 멤버인 Alan Waxman은 2025년 6월 30일 기준으로 Caris Life Sciences, Inc.("CAI")에 대한 수동적 소유권을 공개하는 Schedule 13G를 공동 제출했습니다.

  • TSSP Sub-Fund HoldCo: 23,166,128주 (총 277,932,779주 중 8.3%).
  • Alan Waxman: HoldCo 및 관련 Sixth Street 차량들의 통제를 통해 24,385,399주(8.8%)의 실질적 소유자로 간주됩니다.
  • 주식은 Barnett Equity Holdings, Sixth Street Specialty Lending Inc. 및 관련 투자 LLC를 포함한 다섯 개의 법인에 분산되어 있습니다.

양 제출자는 각각의 주식 수에 대해 단독공동 투표/처분 권한이 전혀 없음을 보고하며, 소유권은 규칙 13d-1(c)에 따라 수동적 투자로 보고됩니다. 추가 거래, 지배권 변경 또는 인증은 공개되지 않았습니다.

Le 28 juillet 2025, TSSP Sub-Fund HoldCo, LLC et son membre gestionnaire Alan Waxman ont conjointement déposé un Schedule 13G révélant une participation passive dans Caris Life Sciences, Inc. ("CAI") au 30 juin 2025.

  • TSSP Sub-Fund HoldCo : 23 166 128 actions (8,3 % des 277 932 779 actions en circulation).
  • Alan Waxman : considéré comme bénéficiaire effectif de 24 385 399 actions (8,8 %) par le contrôle de HoldCo et des entités liées de Sixth Street.
  • Les actions sont réparties entre cinq entités, dont Barnett Equity Holdings, Sixth Street Specialty Lending Inc. et des LLC d’investissement associées.

Les deux déclarants indiquent aucun pouvoir de vote/disposition individuel et partagé sur les actions respectives ; la propriété est déclarée en vertu de la règle 13d-1(c) comme un investissement passif. Aucune transaction supplémentaire, changement de contrôle ou certification n’a été divulgué.

Am 28. Juli 2025 reichten TSSP Sub-Fund HoldCo, LLC und dessen geschäftsführendes Mitglied Alan Waxman gemeinsam einen Schedule 13G ein, in dem sie einen passiven Besitz an Caris Life Sciences, Inc. ("CAI") zum 30. Juni 2025 offenlegten.

  • TSSP Sub-Fund HoldCo: 23.166.128 Aktien (8,3 % von insgesamt 277.932.779 ausstehenden Aktien).
  • Alan Waxman: gilt als wirtschaftlicher Eigentümer von 24.385.399 Aktien (8,8 %) durch Kontrolle von HoldCo und zugehörigen Sixth Street Vehikeln.
  • Die Aktien sind auf fünf Einheiten verteilt, darunter Barnett Equity Holdings, Sixth Street Specialty Lending Inc. und verwandte Investment-LLCs.

Beide Melder geben keine alleinigen und gemeinsamen Stimm- oder Verfügungsrechte über die jeweiligen Aktienbestände an; das Eigentum wird gemäß Regel 13d-1(c) als passives Investment gemeldet. Es wurden keine weiteren Transaktionen, Kontrollwechsel oder Zertifizierungen offengelegt.

Positive
  • Sixth Street-affiliated investors now hold an 8.8 % passive stake in CAI, adding a prominent institutional backer to the shareholder base.
Negative
  • None.

Insights

TL;DR: Sixth Street affiliates reveal ~9 % passive stake in CAI; material for ownership mix but no control intent signaled.

The Schedule 13G indicates that Sixth Street–managed entities, via TSSP Sub-Fund HoldCo, accumulated 23.2 m CAI shares, while managing member Alan Waxman is deemed to control 24.4 m shares. At 8.3-8.8 % of outstanding stock, this represents a significant minority holding that must be reported but remains below activism thresholds. Because the filing is on Form 13G (not 13D), it signals no current intent to influence management, suggesting a passive, possibly credit-linked or crossover equity position typical of Sixth Street. From a valuation standpoint, new institutional support can tighten the float and may improve liquidity. However, absent any transactional detail or future plans, the disclosure is largely informational; fundamental outlook for CAI is unchanged.

Il 28 luglio 2025, TSSP Sub-Fund HoldCo, LLC e il suo membro gestore Alan Waxman hanno presentato congiuntamente un Schedule 13G, dichiarando una partecipazione passiva in Caris Life Sciences, Inc. ("CAI") al 30 giugno 2025.

  • TSSP Sub-Fund HoldCo: 23.166.128 azioni (8,3% delle 277.932.779 azioni in circolazione).
  • Alan Waxman: considerato beneficiario effettivo di 24.385.399 azioni (8,8%) tramite il controllo di HoldCo e dei veicoli correlati di Sixth Street.
  • Le azioni sono distribuite tra cinque entità, tra cui Barnett Equity Holdings, Sixth Street Specialty Lending Inc. e LLC di investimento correlate.

Entrambi i presentatori dichiarano zero poteri di voto o dispositivi individuali e condivisi sulle rispettive azioni; la proprietà è segnalata ai sensi della Regola 13d-1(c) come investimento passivo. Non sono state divulgate ulteriori transazioni, cambiamenti di controllo o certificazioni.

El 28 de julio de 2025, TSSP Sub-Fund HoldCo, LLC y su miembro administrador Alan Waxman presentaron conjuntamente un Schedule 13G, revelando una propiedad pasiva en Caris Life Sciences, Inc. ("CAI") al 30 de junio de 2025.

  • TSSP Sub-Fund HoldCo: 23,166,128 acciones (8.3% de las 277,932,779 en circulación).
  • Alan Waxman: considerado beneficiario efectivo de 24,385,399 acciones (8.8%) a través del control de HoldCo y los vehículos relacionados de Sixth Street.
  • Las acciones están distribuidas entre cinco entidades, incluyendo Barnett Equity Holdings, Sixth Street Specialty Lending Inc. y LLCs de inversión relacionadas.

Ambos declarantes reportan cero poder individual y compartido de voto/disposición sobre las acciones respectivas; la propiedad se informa bajo la Regla 13d-1(c) como una inversión pasiva. No se divulgaron transacciones adicionales, cambios de control ni certificaciones.

2025년 7월 28일, TSSP Sub-Fund HoldCo, LLC와 그 관리 멤버인 Alan Waxman은 2025년 6월 30일 기준으로 Caris Life Sciences, Inc.("CAI")에 대한 수동적 소유권을 공개하는 Schedule 13G를 공동 제출했습니다.

  • TSSP Sub-Fund HoldCo: 23,166,128주 (총 277,932,779주 중 8.3%).
  • Alan Waxman: HoldCo 및 관련 Sixth Street 차량들의 통제를 통해 24,385,399주(8.8%)의 실질적 소유자로 간주됩니다.
  • 주식은 Barnett Equity Holdings, Sixth Street Specialty Lending Inc. 및 관련 투자 LLC를 포함한 다섯 개의 법인에 분산되어 있습니다.

양 제출자는 각각의 주식 수에 대해 단독공동 투표/처분 권한이 전혀 없음을 보고하며, 소유권은 규칙 13d-1(c)에 따라 수동적 투자로 보고됩니다. 추가 거래, 지배권 변경 또는 인증은 공개되지 않았습니다.

Le 28 juillet 2025, TSSP Sub-Fund HoldCo, LLC et son membre gestionnaire Alan Waxman ont conjointement déposé un Schedule 13G révélant une participation passive dans Caris Life Sciences, Inc. ("CAI") au 30 juin 2025.

  • TSSP Sub-Fund HoldCo : 23 166 128 actions (8,3 % des 277 932 779 actions en circulation).
  • Alan Waxman : considéré comme bénéficiaire effectif de 24 385 399 actions (8,8 %) par le contrôle de HoldCo et des entités liées de Sixth Street.
  • Les actions sont réparties entre cinq entités, dont Barnett Equity Holdings, Sixth Street Specialty Lending Inc. et des LLC d’investissement associées.

Les deux déclarants indiquent aucun pouvoir de vote/disposition individuel et partagé sur les actions respectives ; la propriété est déclarée en vertu de la règle 13d-1(c) comme un investissement passif. Aucune transaction supplémentaire, changement de contrôle ou certification n’a été divulgué.

Am 28. Juli 2025 reichten TSSP Sub-Fund HoldCo, LLC und dessen geschäftsführendes Mitglied Alan Waxman gemeinsam einen Schedule 13G ein, in dem sie einen passiven Besitz an Caris Life Sciences, Inc. ("CAI") zum 30. Juni 2025 offenlegten.

  • TSSP Sub-Fund HoldCo: 23.166.128 Aktien (8,3 % von insgesamt 277.932.779 ausstehenden Aktien).
  • Alan Waxman: gilt als wirtschaftlicher Eigentümer von 24.385.399 Aktien (8,8 %) durch Kontrolle von HoldCo und zugehörigen Sixth Street Vehikeln.
  • Die Aktien sind auf fünf Einheiten verteilt, darunter Barnett Equity Holdings, Sixth Street Specialty Lending Inc. und verwandte Investment-LLCs.

Beide Melder geben keine alleinigen und gemeinsamen Stimm- oder Verfügungsrechte über die jeweiligen Aktienbestände an; das Eigentum wird gemäß Regel 13d-1(c) als passives Investment gemeldet. Es wurden keine weiteren Transaktionen, Kontrollwechsel oder Zertifizierungen offengelegt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



TSSP Sub-Fund HoldCo, LLC
Signature:/s/ Joshua Peck
Name/Title:Joshua Peck, Vice President
Date:07/28/2025
Alan Waxman
Signature:/s/ Joshua Peck
Name/Title:Joshua Peck, on behalf of Alan Waxman (*)
Date:07/28/2025

Comments accompanying signature: Joshua Peck is signing on behalf of Mr. Waxman pursuant to an authorization and designation letter dated December 31, 2024, filed herewith.
Exhibit Information

Exhibit 1 - Agreement of Joint Filing Exhibit 2 - Authorization and Designation Letter, dated December 31, 2024, by Alan Waxman (filed herewith)

FAQ

Who filed the Schedule 13G for Caris Life Sciences (CAI)?

TSSP Sub-Fund HoldCo, LLC and its managing member Alan Waxman filed jointly.

How many CAI shares do the reporting persons own?

HoldCo reports 23,166,128 shares; Alan Waxman is deemed to own 24,385,399 shares.

What percentage of Caris Life Sciences’ outstanding stock is represented?

HoldCo owns 8.3 %; Alan Waxman controls 8.8 % of the 277,932,779 shares outstanding.

Is the stake considered passive or activist?

The filing is on Schedule 13G under Rule 13d-1(c), indicating a passive investment.

Under which CUSIP number was the filing made?

The filing references CUSIP 141252107.

When is the ownership date relevant to the filing?

Ownership is reported as of 30 June 2025.
CAI Intl

NASDAQ:CAI

CAI Rankings

CAI Latest News

CAI Latest SEC Filings

CAI Stock Data

8.20B
126.74M
General Rental Centers
Real Estate and Rental and Leasing
Link
US
San Francisco